Moving From Clinical Trials to Precision Medicine: The Role for Predictive Modeling.
Publication
, Journal Article
Pencina, MJ; Peterson, ED
Published in: JAMA
April 26, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 26, 2016
Volume
315
Issue
16
Start / End Page
1713 / 1714
Location
United States
Related Subject Headings
- Thrombosis
- Pyridines
- Platelet Aggregation Inhibitors
- Percutaneous Coronary Intervention
- Myocardial Infarction
- Male
- Humans
- Hemorrhage
- General & Internal Medicine
- Female
Citation
APA
Chicago
ICMJE
MLA
NLM
Pencina, M. J., & Peterson, E. D. (2016). Moving From Clinical Trials to Precision Medicine: The Role for Predictive Modeling. JAMA, 315(16), 1713–1714. https://doi.org/10.1001/jama.2016.4839
Pencina, Michael J., and Eric D. Peterson. “Moving From Clinical Trials to Precision Medicine: The Role for Predictive Modeling.” JAMA 315, no. 16 (April 26, 2016): 1713–14. https://doi.org/10.1001/jama.2016.4839.
Pencina MJ, Peterson ED. Moving From Clinical Trials to Precision Medicine: The Role for Predictive Modeling. JAMA. 2016 Apr 26;315(16):1713–4.
Pencina, Michael J., and Eric D. Peterson. “Moving From Clinical Trials to Precision Medicine: The Role for Predictive Modeling.” JAMA, vol. 315, no. 16, Apr. 2016, pp. 1713–14. Pubmed, doi:10.1001/jama.2016.4839.
Pencina MJ, Peterson ED. Moving From Clinical Trials to Precision Medicine: The Role for Predictive Modeling. JAMA. 2016 Apr 26;315(16):1713–1714.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 26, 2016
Volume
315
Issue
16
Start / End Page
1713 / 1714
Location
United States
Related Subject Headings
- Thrombosis
- Pyridines
- Platelet Aggregation Inhibitors
- Percutaneous Coronary Intervention
- Myocardial Infarction
- Male
- Humans
- Hemorrhage
- General & Internal Medicine
- Female